BACKGROUND: Genetic variation of the estrogen receptor alpha (ESR1) and beta (ESR2) has been associated with components of the metabolic syndrome. METHODS: The relationships of two ESR1 (rs2234693 and rs9340799) and three ESR2 (rs1271572, rs1256049, and rs4986938) polymorphisms with the metabolic syndrome were examined in 532 Caucasian female participants (median age 63.1 years) in the Women's Health Study. Most women (99.1%) were postmenopausal. The associations between ESR1 and ESR2 genotypes and haplotypes with the metabolic syndrome were evaluated. Effect modification by hormone therapy was also assessed. RESULTS: Genotype and haplotype distributions were similar between women with and without metabolic syndrome. We found no consistent associations between the genotypes and haplotypes tested and the metabolic syndrome, or its components, in logistic regression models. No effect modification by hormone therapy use was noted. CONCLUSIONS: No association between these genetic variants in ESR1 and ESR2 and the metabolic syndrome was observed among these Caucasian women. Further investigation regarding the potential involvement of estrogen receptor genes and the metabolic syndrome may be warranted in other ethnic groups.
BACKGROUND: Genetic variation of the estrogen receptor alpha (ESR1) and beta (ESR2) has been associated with components of the metabolic syndrome. METHODS: The relationships of two ESR1 (rs2234693 and rs9340799) and three ESR2 (rs1271572, rs1256049, and rs4986938) polymorphisms with the metabolic syndrome were examined in 532 Caucasian female participants (median age 63.1 years) in the Women's Health Study. Most women (99.1%) were postmenopausal. The associations between ESR1 and ESR2 genotypes and haplotypes with the metabolic syndrome were evaluated. Effect modification by hormone therapy was also assessed. RESULTS: Genotype and haplotype distributions were similar between women with and without metabolic syndrome. We found no consistent associations between the genotypes and haplotypes tested and the metabolic syndrome, or its components, in logistic regression models. No effect modification by hormone therapy use was noted. CONCLUSIONS: No association between these genetic variants in ESR1 and ESR2 and the metabolic syndrome was observed among these Caucasian women. Further investigation regarding the potential involvement of estrogen receptor genes and the metabolic syndrome may be warranted in other ethnic groups.
Authors: Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa Journal: Circulation Date: 2005-09-12 Impact factor: 29.690
Authors: W C Willett; L Sampson; M L Browne; M J Stampfer; B Rosner; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1988-01 Impact factor: 4.897
Authors: H W Deng; J Li; J L Li; R Dowd; K M Davies; M Johnson; G Gong; H Deng; R R Recker Journal: J Clin Endocrinol Metab Date: 2000-08 Impact factor: 5.958
Authors: Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: K Rosenkranz; A Hinney; A Ziegler; H Hermann; M Fichter; H Mayer; W Siegfried; J K Young; H Remschmidt; J Hebebrand Journal: J Clin Endocrinol Metab Date: 1998-12 Impact factor: 5.958
Authors: Keith L Keene; Josyf C Mychaleckyj; Shelly G Smith; Tennille S Leak; Peter S Perlegas; Carl D Langefeld; David M Herrington; Barry I Freedman; Stephen S Rich; Donald W Bowden; Michèle M Sale Journal: Hum Genet Date: 2008-02-28 Impact factor: 4.132
Authors: Andreia Soares da Silva; Tatiana Lins Carvalho; Kleyton Palmeira do Ó; Débora Nascimento da Nóbrega; Roberta Dos Santos Souza; Victor Fernando da Silva Lima; Isabela Cristina Cordeiro Farias; Taciana Furtado de Mendonça Belmont; Maria do Socorro de Mendonça Cavalcanti; Demócrito de Barros Miranda-Filho Journal: Mol Biol Rep Date: 2020-04-22 Impact factor: 2.316